Vote Scores
Filings read through

Skye Bioscience, Inc.: how funds voted at the meeting of 6 Jun 2025

Ticker
SKYE
Meeting
Season
year to 30 June 2025
Filers reporting
120
Ballot items
4

120 filers on Form N-PX reported votes at the Skye Bioscience, Inc. meeting of 6 Jun 2025. The records fall into 4 ballot items. The page lists them in ballot order: items of the company first, then proposals from security holders. Each bar shows how the reporting filers split. It is not the result of the meeting.

This meeting is in the year to 30 June 2025. The latest season on file is the year to 30 June 2026. The page of Skye Bioscience, Inc. has the latest meeting.

If the reporting person has not received confirmation of the actual number of votes cast prior to filing a report on Form N-PX, the numbers reported may reflect the number of shares instructed to be cast. A reporting person is not required to amend a previously filed Form N-PX report if the reporting person subsequently receives confirmation of the actual number of votes cast.

The words of the SEC. Source: Form N-PX and its instructions, Special Instructions D.5 and D.8, copied on .

The words of this site: the filer writes each filing. The SEC does not say that it checked the votes. A lender does not vote shares that are on loan. A later filing (Form N-PX/A) can replace an earlier filing, and the site uses the latest.

The figures on this page count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting.

The page gives records. It gives no investment advice and no advice on how to vote.

Season on this page: year to 30 June 2025. Filings read through . How the figures are made

The ballot

ForAgainstAbstain, withhold or otherAmber tick: the part cast against management

  1. Item 1: Director elections

    6 nominees. 63.6% of the reported votes are for. 33 filers withheld from or voted against at least one nominee.

    372 vote records from 37 filers. 11 of the 37 filers that marked the item voted against management.

    • Positions of 21 fund families
    • For 15
    • Abstain or withhold 6
    • Against management 6
  2. Item 2: Advisory vote on executive pay (say-on-pay)

    152 vote records from 117 filers. 64 of the 110 filers that marked the item voted against management. 7 filers gave no management mark.

    • Positions of 28 fund families
    • For 8
    • Against 20
    • Against management 20
  3. Item 3: Frequency of the say-on-pay vote

    One year: 104 filers. For: 1 filer. Against: 1 filer. Two years: 1 filer. Three years: 1 filer. Not applicable: 1 filer.

    150 vote records from 114 filers. 2 of the 108 filers that marked the item voted against management. 6 filers gave no management mark.

    • Positions of 28 fund families
    • Split or no vote 28
  4. Item 4: Audit-related items (auditor ratification)

    62 vote records from 37 filers. 0 of the 37 filers that marked the item voted against management.

    • Positions of 21 fund families
    • For 21

Positions of the fund families

A position is not the vote of each fund. The position of a family is the way most of the shares reported by its filers were voted. Funds of one family can vote in different ways.

KeyForAgainstAbstain or withholdSplit or no voteAgainst management

Fund families at Skye Bioscience, Inc., meeting of 6 Jun 2025Families in name order. "Abstain" includes withhold. "Split" includes no vote. "No report" means that no filer of the family listed the item.
Fund family2. Say-on-pay3. Pay-vote frequency4. Auditor
AllianceBernsteinAgainst, against managementSplitNo report
BlackRock and iSharesAgainst, against managementSplitFor
BNY MellonAgainst, against managementSplitNo report
Charles SchwabForSplitFor
Columbia ThreadneedleAgainst, against managementSplitFor
DWSAgainst, against managementSplitFor
EquitableAgainst, against managementSplitFor
FidelityAgainst, against managementSplitFor
Global XAgainst, against managementSplitFor
Goldman SachsAgainst, against managementSplitFor
Guggenheim and RydexAgainst, against managementSplitFor
InvescoAgainst, against managementSplitNo report
J.P. MorganAgainst, against managementSplitNo report
Lincoln FinancialForSplitFor
Morgan Stanley, Eaton Vance and CalvertAgainst, against managementSplitFor
NationwideAgainst, against managementSplitFor
Neuberger BermanForSplitNo report
Northern Trust and FlexSharesForSplitFor
Nuveen and TIAAForSplitFor
Pacific Life fundsAgainst, against managementSplitFor
PGIM and PrudentialForSplitNo report
PrincipalAgainst, against managementSplitNo report
ProShares and ProFundsAgainst, against managementSplitFor
State Street and SPDRForSplitFor
T. Rowe PriceAgainst, against managementSplitFor
VanguardForSplitFor
Victory CapitalAgainst, against managementSplitFor
VoyaAgainst, against managementSplitFor

Questions

How many filers reported votes at the Skye Bioscience, Inc. meeting?
120 Form N-PX filers reported votes at the meeting of 6 Jun 2025. On say-on-pay, 64 of 110 filers that marked the item voted against management (58.2%).
Is this the result of the meeting?
No. The page counts the filers that report on Form N-PX, and the shares they reported. Skye Bioscience, Inc. reports the result of a vote on Form 8-K.
Why does the page show counts only for director elections?
A director record names the nominee. This site has no page and no row about a person. For director elections it keeps the number of nominees and the split of votes.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings that list Skye Bioscience, Inc. with a meeting date within three days of 6 Jun 2025. A proposal title is the most common wording among filers. Where a wording can name a person, the SEC category is shown. The filers wrote the filings. Filings read through .